v3.26.1
Segment reporting - Schedule of Operating Segment Assets and Liabilities (Details) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Operating Segment Assets and Liabilities [Abstract]    
Total assets $ 1,361,851 $ 1,163,986
Total liabilities 874,176 748,610
Additions to non-current assets 24,498 419,530
Operating segments    
Operating Segment Assets and Liabilities [Abstract]    
Total assets 1,080,124 976,791
Total liabilities 325,165 333,221
Additions to non-current assets 24,498 411,690
Operating segments | Precision Medicine    
Operating Segment Assets and Liabilities [Abstract]    
Total assets 323,308 233,252
Total liabilities 157,343 159,523
Additions to non-current assets 668 19,503
Operating segments | Therapeutics    
Operating Segment Assets and Liabilities [Abstract]    
Total assets 232,997 228,110
Total liabilities 25,828 17,099
Additions to non-current assets 172 67,715
Operating segments | Manufacturing Solutions    
Operating Segment Assets and Liabilities [Abstract]    
Total assets 523,819 515,429
Total liabilities 141,994 156,599
Additions to non-current assets 23,658 324,472
Reconciling items    
Operating Segment Assets and Liabilities [Abstract]    
Total assets 281,727 187,195
Total liabilities 549,011 415,389
Additions to non-current assets $ 0 $ 7,840